Medtronic Asks Users Which Tubeless Pump Color They Like

Medtronic has ramped up excitement around its upcoming tubeless insulin pump after sending out a survey to select users—asking for feedback on potential color options for the new device. The survey showcases five different color choices and invites users to weigh in on their preferences. While the final product probably won’t include swappable colors, this feedback will help Medtronic decide which single color to move forward with for the official launch. It’s a small but meaningful way the company is involving the diabetes community in the development process.

This survey also signals that the tubeless pump is progressing further along in its development. Medtronic has yet to officially unveil the final design or release timeline, but the survey is a promising sign that the project is moving closer to reality. The design shown in the survey pictures looks remarkably different from the images we saw last month. For users who have been eagerly awaiting a tubeless option from Medtronic, this glimpse into the process offers hope that it’s not too far off.

What We Know So Far About Medtronic’s Tubeless Pump

Medtronic’s upcoming tubeless pump is shaping up to be a serious contender in the patch pump space. It will feature a 300-unit insulin reservoir, offering 50% more insulin than both the Omnipod and Tandem Mobi—an especially big deal for people with Type 2 diabetes or higher insulin needs. The pump is also expected to support a 7-day wear time, thanks in part to Medtronic’s Extended Infusion Set technology. And rather than a single-piece design like the Omnipod, it may be modular with reusable components, which could have major implications for sustainability and cost.

Want to dive deeper? Read more about both pumps here and watch my full video below, where I break down everything we know about Medtronic’s upcoming tubeless pump—plus what’s coming in their next-generation 8-series pump currently in development.

Want to help advance diabetes research and get paid for it? 

Head to the T1D Exchange Registry, where you can help push diabetes tech and research forward! After a quick 15-minute survey, you’ll gain access to a personal portal with survey and clinical trial opportunities—some of which offer compensation.

Sign up here to be part of the future of diabetes innovation. Available for U.S. residents only.

Product link disclosure - In order to provide free content, we use affiliate links. This means if you make purchases through certain links, we may earn a small commission (at no extra cost to you).